NCT06431893Phase 3Enrolling by invitation

A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE) (ENSEMBLE)

Study sponsor: Travere Therapeutics, Inc. · TVTX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2030-08Estimated
Enrollment · participants100Estimated
Source updated2026-11-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Jan 2027. After: Aug 2030.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview